IN VIVO Execs On The Move, June 2014
Executive Summary
Recent executive-level company changes and promotions in the biopharma, medical device, and diagnostics industries.
| Table |
|---|
Advertisement
Topics
- Industries
- BioPharmaceutical
- Medical Device
Related Companies
- Novavax Inc.
- Dyax Corp.
- Dicerna Pharmaceuticals Inc.
- Clinical Innovations LLC
- Integra LifeSciences Holdings Corp.
- GenSight Biologics SA
- Alphatec Holdings Inc.
- LivaNova PLC
- Actinium Pharmaceuticals Inc.
- Laboratory Corp. of America Holdings
- Z-Medica LLC
- Tokai Pharmaceuticals Inc.
- Sanovas Inc.
- Chugai Pharma USA LLC
- GlycoMimetics Inc.
- Actinium Pharmaceuticals Inc.
- Histogenics Corp.
- CardioDx Inc.
- Sanovas Inc.
- Idera Pharmaceuticals Inc.
- Xtant Medical Holdings Inc.
- Protea Biosciences Group Inc.
- MediWound Ltd.
- Biogen Inc.
- Aptus Endosystems Inc.
- Insmed Inc.
- Sequana Medical AG
- Intercept Pharmaceuticals Inc.
- Rotation Medical Inc.
- Loxo Oncology Inc.
- Gynesonics Inc.
- T2 Biosystems Inc.
- Trevena Inc.
- Foundation Medicine Inc.
- CardioDx Inc.
- Biogen Inc.
- Elekta AB
- Forum Pharmaceuticals Inc.
- Sesen Bio Inc.
- Lupin Ltd.
- Alcresta Inc.
- Hansen Medical Inc.
- Endo International PLC
- Kite Pharma Inc.
- Impax Laboratories Inc.
- Chimerix Inc.
- Vascular Pathways Inc.
- Aqua Pharmaceuticals LLC
- MediWound Ltd.
- Elekta AB
- MediWound Ltd.
- LivaNova PLC
- OrbusNeich
- Genomind LLC
- Vermillion Inc.
- Spectrum Pharmaceuticals Inc.
- Spectrum Pharmaceuticals Inc.
- Sequenom Inc.
- Astellas Pharma Inc.
- Alliance HealthCare Services
Advertisement
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
IV004241
Ask The Analyst
Ask the Analyst is free for subscribers. Submit your question and one of our analysts will be in touch.
Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.
All fields are required.
IV004241
Email Article
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.